Bernard D. King

572 total citations
17 papers, 410 citations indexed

About

Bernard D. King is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Hepatology. According to data from OpenAlex, Bernard D. King has authored 17 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 4 papers in Surgery and 3 papers in Hepatology. Recurrent topics in Bernard D. King's work include Cardiac Valve Diseases and Treatments (4 papers), Hepatitis C virus research (3 papers) and Cardiovascular Issues in Pregnancy (3 papers). Bernard D. King is often cited by papers focused on Cardiac Valve Diseases and Treatments (4 papers), Hepatitis C virus research (3 papers) and Cardiovascular Issues in Pregnancy (3 papers). Bernard D. King collaborates with scholars based in United States, Netherlands and Bulgaria. Bernard D. King's co-authors include Harisios Boudoulas, Charles F. Wooley, Peter B. Baker, Albert J. Kolibash, M. A. Clark, James W. Kilman, Nobuhisa Baba, C F Wooley, David Masson and Minako Ishibashi and has published in prestigious journals such as Circulation, CHEST Journal and Hypertension.

In The Last Decade

Bernard D. King

17 papers receiving 387 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bernard D. King United States 10 218 123 93 65 57 17 410
Marcus Vinícius Simões Brazil 12 124 0.6× 61 0.5× 121 1.3× 67 1.0× 77 1.4× 24 369
DK Kim South Korea 12 111 0.5× 41 0.3× 121 1.3× 23 0.4× 11 0.2× 21 355
Donald Easton United States 9 134 0.6× 165 1.3× 73 0.8× 19 0.3× 4 0.1× 16 475
Yong Hoon Kim South Korea 9 54 0.2× 227 1.8× 79 0.8× 88 1.4× 12 0.2× 20 473
Yumiko Ikemoto Japan 8 138 0.6× 39 0.3× 72 0.8× 116 1.8× 6 0.1× 16 282
Mitsuru Seki Japan 13 216 1.0× 168 1.4× 206 2.2× 78 1.2× 10 0.2× 38 474
Davide Rosati Italy 12 17 0.1× 48 0.4× 99 1.1× 49 0.8× 32 0.6× 37 361
C. Betterle Italy 11 115 0.5× 90 0.7× 163 1.8× 61 0.9× 41 0.7× 16 541
Charles Neave United States 9 26 0.1× 79 0.6× 132 1.4× 137 2.1× 116 2.0× 13 436
Mona N. Rizeq United States 7 415 1.9× 34 0.3× 191 2.1× 195 3.0× 7 0.1× 10 591

Countries citing papers authored by Bernard D. King

Since Specialization
Citations

This map shows the geographic impact of Bernard D. King's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernard D. King with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernard D. King more than expected).

Fields of papers citing papers by Bernard D. King

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernard D. King. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernard D. King. The network helps show where Bernard D. King may publish in the future.

Co-authorship network of co-authors of Bernard D. King

This figure shows the co-authorship network connecting the top 25 collaborators of Bernard D. King. A scholar is included among the top collaborators of Bernard D. King based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernard D. King. Bernard D. King is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
King, Bernard D., et al.. (2015). MicroRNA-122 associates with serum apolipoprotein B but not liver fibrosis markers in CHC genotype 1 infection. Journal of Medical Virology. 87(10). 1722–1726. 6 indexed citations
2.
3.
4.
Manns, M.P., Eric Lawitz, A. I. M. Hoepelman, et al.. (2010). 273 SHORT TERM SAFETY, TOLERABILITY, PHARMACOKINETICS AND PRELIMINARY ACTIVITY OF GS-9450, A SELECTIVE CASPASE INHIBITOR, IN PATIENTS WITH CHRONIC HCV INFECTION. Journal of Hepatology. 52. S114–S115. 10 indexed citations
5.
Masson, David, Masahiro Koseki, Minako Ishibashi, et al.. (2009). Increased HDL Cholesterol and ApoA-I in Humans and Mice Treated With a Novel SR-BI Inhibitor. Arteriosclerosis Thrombosis and Vascular Biology. 29(12). 2054–2060. 62 indexed citations
6.
Miller, Stephen G., et al.. (2007). Abstract 680: KC706, an Oral p38 MAP Kinase Inhibitor, Increases HDL-C. Circulation. 116(suppl_16). 1 indexed citations
7.
King, Bernard D., et al.. (2005). Mechanical Properties of Counter-Gravity Cast IN718. 123–133. 1 indexed citations
8.
Boudoulas, Harisios, Albert J. Kolibash, Peter B. Baker, Bernard D. King, & Charles F. Wooley. (1989). Mitral valve prolapse and the mitral valve prolapse syndrome: A diagnostic classification and pathogenesis of symptoms. American Heart Journal. 118(4). 796–818. 84 indexed citations
9.
King, Bernard D., et al.. (1987). Absence of hypertension despite chronic marked elevations in plasma norepinephrine in conscious dogs.. Hypertension. 9(6). 582–590. 35 indexed citations
10.
Boudoulas, Harisios, Bernard D. King, & Charles F. Wooley. (1984). Mitral Valve Prolapse: A Marker for Anxiety or Overlapping Phenomenon ?. Psychopathology. 17(1). 98–106. 13 indexed citations
11.
King, Bernard D.. (1983). Impotence During Therapy With Verapamil. Archives of Internal Medicine. 143(6). 1248–1248. 15 indexed citations
12.
Ambrose, John A., et al.. (1983). Early diastolic motion of the posterior aortic root as an index of left ventricular filling. Journal of Clinical Ultrasound. 11(7). 357–364. 3 indexed citations
13.
King, Bernard D., et al.. (1982). Anomalous origin of the right coronary artery from the ascending aorta above the left coronary sinus. Catheterization and Cardiovascular Diagnosis. 8(3). 277–280. 20 indexed citations
14.
King, Bernard D., et al.. (1982). Clinical Use of Oral Verapamil in Chronic and Paroxysmal Atrial Fibrillation. CHEST Journal. 81(3). 308–311. 23 indexed citations
15.
King, Bernard D., M. A. Clark, Nobuhisa Baba, James W. Kilman, & C F Wooley. (1982). "Myxomatous" mitral valves: collagen dissolution as the primary defect.. Circulation. 66(2). 288–296. 82 indexed citations
16.
King, Bernard D., Harisios Boudoulas, Mary E. Fontana, & Charles F. Wooley. (1980). Mitral valve prolapse syndrome: Anthropometric, sexual and clinical features. The American Journal of Cardiology. 45(2). 443–443. 3 indexed citations
17.
King, Bernard D., et al.. (1974). NEUROFIBROMATOSIS IN CHILDREN. Pediatric Research. 8(4). 441–441. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marcus Vinícius Simões Breakdown of academic impact, for papers by DK Kim Breakdown of academic impact, for papers by Donald Easton Breakdown of academic impact, for papers by Yong Hoon Kim Breakdown of academic impact, for papers by Yumiko Ikemoto Breakdown of academic impact, for papers by Mitsuru Seki Breakdown of academic impact, for papers by Davide Rosati Breakdown of academic impact, for papers by C. Betterle Breakdown of academic impact, for papers by Charles Neave Breakdown of academic impact, for papers by Mona N. Rizeq
Rankless by CCL
2026